Program

Home

Antiviral and medical approaches to prevention

Abdool Karim, Salim 2011
Salim S Abdool Karim, MBChB, PhD is a clinical infectious diseases epidemiologist whose main current research interests are in microbicides and vaccines to prevent HIV infection and implementing antiretroviral therapy in resource constrained settings. He is Pro Vice-Chancellor (Research) at the University of KwaZulu-Natal in Durban, South Africa. He is also Professor of Clinical Epidemiology at the Mailman School of Public Health at Columbia University and Adjunct Professor of Medicine

at the Weill Medical College of Cornell University. He is Director of CAPRISA – Centre for the AIDS Programme of Research in South Africa.
Dr Abdool Karim has published widely on infectious diseases, including AIDS, measles and hepatitis B and co-edited the textbook that is widely used to teach epidemiology in South Africa as well as a book on HIV/AIDS in South Africa.  He is an Associate Editor of AIDS Clinical Care. In 2009, he was awarded the TWAS Prize in Medical Sciences. He is co-inventor on three patents; two of these are vaccine-related patents which have been included in candidate HIV vaccines.
He led the NIH-funded HPTN 035 microbicide trial of PRO2000 gel that showed a modest reduction in HIV infection in women and was the Co-Principal Investigator of the the recently completed CAPRISA 004 tenofoivr gel trial which provided proof of concept for microbicides. He is Chair of the Scientific and Technical Advisory Group for Reproductive Health at the World Health Organization and a Member of the UNAIDS Prevention Reference Group. He is a Steering Committee member of the Gate’s Foundation’s Global HIV Prevention Working Group and an Executive Committee Member of the NIH funded Microbicide Trials Network.  He is a member of the Academy of Science in South Africa and a Fellow of the Royal Society of South Africa.